Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection
Open Access
- 11 August 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 65 (7) , 1218-1221
Abstract
We estimated 30-day all-cause and Clostridium difficile infection (CDI)–associated hospital readmissions in participants at high risk of recurrent CDI enrolled in MODIFY I/II. Bezlotoxumab-treated inpatients experienced fewer CDI-associated readmissions compared with placebo-treated inpatients, notably in participants aged ≥65 years and with severe CDI. Clinical Trials Registration. NCT01241552 (MODIFY I) and NCT01513239 (MODIFY II).Keywords
Funding Information
- National Institutes of Health (UM1AI104681)
- Merck & Co., Inc.
This publication has 32 references indexed in Scilit:
- Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled TrialsClinical Infectious Diseases, 2014
- NAP1 Strain Type Predicts Outcomes From Clostridium difficile InfectionClinical Infectious Diseases, 2014
- Effect of ribotype on all-cause mortality following Clostridium difficile infectionJournal of Hospital Infection, 2013
- Burden of Clostridium difficile on the Healthcare SystemClinical Infectious Diseases, 2012
- Can we identify patients at high risk of recurrent Clostridium difficile infection?Clinical Microbiology and Infection, 2012
- Risk Factors Associated With Complications and Mortality in Patients With Clostridium difficile InfectionClinical Infectious Diseases, 2011
- Fidaxomicin versus Vancomycin forClostridium difficileInfectionNew England Journal of Medicine, 2011
- Clostridium difficile infection in Europe: a hospital-based surveyThe Lancet, 2011
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Comparative analysis of two ratesStatistics in Medicine, 1985